Cargando…
Erratum: Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Autor principal: | Loeffler, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389310/ https://www.ncbi.nlm.nih.gov/pubmed/25880657 http://dx.doi.org/10.1186/s12974-015-0290-z |
Ejemplares similares
-
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2014) -
Intravenous immunoglobulin and Alzheimer’s disease: what now?
por: Loeffler, David A
Publicado: (2013) -
Erratum to: Complex Regional Pain Syndrome Treated with Intravenous Immunoglobulin in a Patient with Common Variable Immune Deficiency
por: Tachdjian, Raffi
Publicado: (2014) -
Erratum to "Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study"
por: Choi, Young Un, et al.
Publicado: (2023) -
Erratum: Alzheimer's disease drug development pipeline: 2023
Publicado: (2023)